Ilomedin

Iloprost trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as a solution for injection for intravenous use. It treats pulmonary arterial hypertension, digital ulcers associated with systemic sclerosis, and helps prevent vasospasm in peripheral vascular surgery.

GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ilomedin, a prostacyclin analog, is used in conditions characterized by pulmonary vascular resistance or peripheral vasospasm.

- Pulmonary arterial hypertension: improves exercise capacity and delays disease progression. - Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces new ulcer formation. - Prevention of vasospasm in peripheral vascular surgery: maintains vessel patency during and after surgical procedures.

Adverse reactions may occur with Ilomedin administration.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Nausea: occasional gastrointestinal upset. - Jaw pain: discomfort during mastication. - Hypotension: mild drop in blood pressure. - Cough: dry or productive.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure decline requiring intervention. - Pulmonary edema: fluid accumulation in the lungs. - Significant bleeding: due to platelet inhibition. - Thrombocytopenia: reduced platelet count. - Arrhythmia: abnormal heart rhythm. - Anaphylaxis: rare severe allergic reaction.

Careful monitoring is required when using Ilomedin.

- Blood pressure monitoring: check before and during infusion. - Bleeding risk assessment: evaluate patients on anticoagulants. - Severe hypotension avoidance: do not administer to patients with unstable hemodynamics. - Pregnancy caution: use only if potential benefit justifies risk. - Renal/hepatic impairment: adjust therapy based on clinical response. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin may interact with other medications affecting vascular tone or coagulation.

Major Interactions (Avoid): - Concurrent potent vasodilators: risk of profound hypotension. - Anticoagulants/antiplatelet agents: increased bleeding tendency. - Endothelin receptor antagonists: additive pulmonary vasodilatory effect.

Moderate Interactions (Monitor Closely): - Aspirin or NSAIDs: may enhance bleeding risk. - Other prostacyclin analogs: potential for overlapping side‑effects. - CYP450 inhibitors: may alter metabolism, requiring observation.